KATLYN PEELE: Open Payments
NPI 1649641093 · BELHAVEN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 71 payments from 15 companies in 2025. Trend: 2023 $1,211 · 2024 $1,278 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 20 | $183 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $171 |
| AstraZeneca Pharmaceuticals LP | 4 | $167 |
| Novo Nordisk Inc | 13 | $152 |
| PFIZER INC. | 5 | $81 |
| ABBVIE INC. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $44 |
| Corcept Therapeutics | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: FREESTYLE LIBRE 2, XIFAXAN, BREZTRI, Wegovy, VRAYLAR, Rybelsus, NURTEC ODT, GEMTESA.
Industry payments across NC — which companies pay providers there.
